Open AccessPossibility of the use of serological method for the determination of immunoglobuline a antibody against early antigene of Epstein-Barr virus as a marker in the diagnosis of nasopharyngeal tumors
Author(s) -
Svetlana Stošić-Divjak,
Branislava Djukić,
Z Petrović,
Vladimir Nešić,
J Alek Racic,
Zoran Tatić,
Vladimir Kanjuh
Publication year - 2005
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0510739s
Subject(s) - nasopharyngeal carcinoma , medicine , serology , titer , carcinoma , epstein–barr virus , antibody , virus , gastroenterology , tumor marker , immunology , cancer , radiation therapy
According to the data from immunological, biological and molecular researches, there is a close association between the undifferentiated carcinoma of nasopharyngeal type (UCNT) and Epstein-Barr virus (EBV). To use IgA EA antibody as a serological marker in our patients with nasopharyngeal carcinoma from a clinical viewpoint.